Anti-VACV [SC212]
Ab03517-23.0
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Overview
- SupplierAbsolute Antibody
- Product NameAnti-VACV [SC212]
- Delivery Days Customer7
- Antibody SpecificityThe antibody is specific for VACV.
- Application Supplier NoteThe scFv fragment was converted to human IgG1 (VC212). The binding affinity of VC212 was estimated by competition ELISA to IC50 values 22 microg/ml (146.67 nM). The humanized version of the antibody neutralized the VACV, as evidenced by the plaque reduction neutralization test result with a PRNT50 of ~0.16 mg/ml (~1.07 microM) (Shin et al., 2019; PMID: 30856707).
- ApplicationsELISA, Neutralisation/Blocking
- Applications SupplierELISA; in vitro neutralization
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSC212
- HostRabbit
- IsotypeIgG
- Scientific DescriptionThis full-length chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format for improved compatibility with existing reagents assays and techniques.
- ReactivityVirus
- Reactivity SupplierVaccinia virus
- Reactivity Supplier NoteA phage display library of human single chain variable fragment (scFv) antibodies was constructed from the B cells of healthy volunteers boosted by the VACV vaccine. Human scFv was isolated by panning against VACV.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203